A Phase IIa (Pilot) Study of Neoadjuvant Chemotherapy With Folinic Acid, 5-FU, Irinotecan and Oxaliplatin (FOLFIRINOX) With Digoxin in Patients With Resectable Pancreatic Cancer
Summary
The purpose of this phase II study is to evaluate the safety and efficacy of digoxin in combination with FOLFIRINOX in patients with resectable pancreatic cancer.
General Information
NCT#: NCT04141995
Study ID: 668-19
Trial Phase: Phase II
Trial Sponsor: Jean Grem, MD
Therapies Used in This Trial: FOLFIRINOX, Digoxin